• Login
    View Item 
    •   Knowledge Repository Home
    • School of Basic and Applied Sciences
    • Department of Animal Sciences
    • Animal Sciences-Research Publications
    • View Item
    •   // Knowledge Repository Home
    • // School of Basic and Applied Sciences
    • // Department of Animal Sciences
    • // Animal Sciences-Research Publications
    • // View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    Knowledge RepositorySchools & CollectionsBy Issue DateAuthorsTitlesSubjectsBy Submit DateThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Submit Date

    My Account

    LoginRegister

    Ginkgolide B Revamps Neuroprotective Role of Apurinic/Apyrimidinic Endonuclease 1 and Mitochondrial Oxidative Phosphorylation Against Ab 25–35 -Induced Neurotoxicity in Human Neuroblastoma Cells

    Thumbnail
    View/Open
    8.pdf (328.2Kb)
    Date
    2015
    Author
    Kaur, Navrattan
    Dhiman, Monisha
    Perez-Polo, J. Regino
    Mantha, Anil K.
    Metadata
    Show full item record
    Abstract
    Accumulating evidence points to roles for oxidative stress, amyloid beta (Aβ), and mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD). In neurons, the base excision repair pathway is the predominant DNA repair (BER) pathway for repairing oxidized base lesions. Apurinic/apyrimidinic endonuclease 1 (APE1), a multifunctional enzyme with DNA repair and reduction–oxidation activities, has been shown to enhance neuronal survival after oxidative stress. This study seeks to determine 1) the effect of Aβ25–35 on reactive oxygen species (ROS)/reactive nitrogen species (RNS) levels, 2) the activities of respiratory complexes (I, III, and IV), 3) the role of APE1 by ectopic expression, and 4) the neuromodulatory role of ginkgolide B (GB; from the leaves of Ginkgo biloba). The pro-oxidant Aβ25–35 peptide treatment increased the levels of ROS/RNS in human neuroblastoma IMR-32 and SH-SY5Y cells, which were decreased after pretreatment with GB. Furthermore, the mitochondrial APE1 level was found to be decreased after treatment with Aβ25–35 up to 48 hr, and the level was increased significantly in cells pretreated with GB. The oxidative phosphorylation (OXPHOS; activities of complexes I, III, and IV) indicated that Aβ25–35 treatment decreased activities of complexes I and IV, and pretreatment with GB and ectopic APE1 expression enhanced these activities significantly compared with Aβ25–35 treatment. Our results indicate that ectopic expression of APE1 potentiates neuronal cells to overcome the oxidative damage caused by Aβ25–35. In addition, GB has been shown to modulate the mitochondrial OXPHOS against Aβ25–35-induced oxidative stress and also to regulate the levels of ROS/RNS in the presence of ectopic APE1. This study presents findings from a new point of view to improve therapeutic potential for AD via the synergistic neuroprotective role played by APE1 in combination with the phytochemical GB. © 2015 Wiley Periodicals, Inc.
    Journal
    Journal Of Neuroscience Reserach
    URI
    http://210.212.34.21/handle/32116/375
    URL
    https://onlinelibrary.wiley.com/doi/abs/10.1002/jnr.23565
    DOI
    10.1002/jnr.23565
    Collections
    • Animal Sciences-Research Publications [78]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Initiatives by University Library 
    Central University of Punjab
     

     


    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Initiatives by University Library 
    Central University of Punjab